title: Therapeutic use of an anti-ErbB3 monoclonal antibody.
abstract: Emerging evidence suggests that the catalytically inactive ErbB3 (HER3) protein plays a fundamental role in normal tyrosine kinase receptor signaling as well as in aberrant functioning of these signaling pathways, resulting in several forms of human cancers and some mental disorders. Here we report the generation of a specific anti-ErbB3 antibody intended for use in diagnosing disease or therapeutic application. By using the hybridoma technique, one cell line (2E(12)C(3)) stably producing anti-ErbB3 antibody was obtained. Its molecular weight was about 185 kDa and its isotype was IgG 2a and κ, respectively. The affinity constant (Kaff) of the anti-ErbB3 MAb was 5.83×10(10) M(-1). This antibody may become a useful tool for diagnostic and therapeutic targeting of ErbB3-expressing cancers or helpful in highlighting the etiology of schizophrenia.
authors: Department of Psychiatry, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
authors: Na
authors: N
authors: Li
authors: Yanchun
authors: Y
authors: Yang
mesh_terms: D000818:Animals; D058846:Antibodies, Monoclonal, Murine-Derived / Q000096:biosynthesis* / Q000276:immunology / Q000627:therapeutic use; D000912:Antibodies, Neoplasm / Q000096:biosynthesis* / Q000276:immunology / Q000627:therapeutic use; D000915:Antibody Affinity; D045744:Cell Line, Tumor; D005260:Female; D006801:Humans; D006825:Hybridomas; D007142:Immunoglobulin gamma-Chains / Q000096:biosynthesis* / Q000276:immunology / Q000627:therapeutic use; D051379:Mice; D008807:Mice, Inbred BALB C; D020893:Receptor, ErbB-3 / Q000276:immunology* / Q000378:metabolism
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000912:Antibodies, Neoplasm; D007142:Immunoglobulin gamma-Chains; D020893:Receptor, ErbB-3